Authors: KOREN MJ SMITH DG HUNNINGHAKE DB DAVIDSON MH MCKENNEY JM WEISS SR SCHROTT HG HENLEY RW TRESH P MCLAIN RW BAKKERARKEMA RG BLACK DM

Citation: Mj. Koren et al., THE COST OF REACHING NATIONAL-CHOLESTEROL-EDUCATION-PROGRAM (NCEP) GOALS IN HYPERCHOLESTEROLEMIC PATIENTS - A COMPARISON OF ATORVASTATIN, SIMVASTATIN, LOVASTATIN AND FLUVASTATIN, PharmacoEconomics, 14(1), 1998, pp. 59-70

Authors: BLACK D DAVIDSON M KOREN M BAKKERARKEMA R TRESH P MCLAIN R SMITH D HUNNINGHAKE D

Citation: D. Black et al., COST-EFFECTIVENESS OF TREATMENT TO NATIONAL CHOLESTEROL EDUCATION PANEL (NCEP) TARGETS WITH HMG-COA REDUCTASE INHIBITORS - TRIAL DESIGN, PharmacoEconomics, 12(2), 1997, pp. 278-285

Authors: KOREN M TRESH P SMITH D BLACK DM

Citation: M. Koren et al., COMPARISON OF COST OF RESOURCE UTILIZATION WITH ATORVASTATIN VERSUS FLUVASTATIN, LOVASTATIN AND SIMVASTATIN IN PATIENTS WITH CHD AND OR PVD/, Atherosclerosis, 134(1-2), 1997, pp. 51-51

Authors: KOREN M TRESH P SMITH D BLACK DM

Citation: M. Koren et al., COST OF RESOURCE UTILIZATION OF ATORVASTATIN COMPARED WITH FLUVASTATIN, LOVASTATIN AND SIMVASTATIN IN PATIENTS WITH RISK-FACTORS FOR CHD, Atherosclerosis, 134(1-2), 1997, pp. 52-52